Our Services
Medical Information
Helpful Resources
Published on: 9/23/2026
The RSV vaccine is currently a one-time dose for most adults, not an annual shot like the flu vaccine, with CDC guidance recommending a single dose for adults 75 and older and for adults 50 to 74 who face higher risk. Protection appears to last through at least two to three RSV seasons, so repeat doses are not advised for people who have already been vaccinated. Pregnancy is the exception, since the maternal RSV vaccine is given during each pregnancy, typically between 32 and 36 weeks and during RSV season, to protect the newborn. Timing, eligibility, and whether your earlier dose still counts depend on your age, health conditions, and which product you received. There are several important details to consider, including who may need future doses as recommendations evolve, so see below to understand more.
If you are coughing, wheezing, or feeling feverish and unsure whether RSV, flu, COVID-19, or something else is behind it, guessing can delay care that works best early. A free, instant, online symptom check takes only a few minutes, asks the same kinds of questions a clinician would, and helps you see which conditions fit your pattern of symptoms. It also helps you decide whether to rest at home, book a visit, or seek urgent care, and it gives you clear notes to share with your doctor so your appointment is more productive. Understanding your symptoms now puts you in a stronger position to ask the right questions about vaccination and treatment.
Last reviewed for medical accuracy: 09/23/2025
How Often to Get the RSV Vaccine
Respiratory syncytial virus (RSV) is a common respiratory infection that can cause anything from mild cold-like symptoms to severe illness. While most people recover in a week or two, RSV can be serious—especially for infants, older adults and those with certain medical conditions. Vaccination is now available to help reduce the risk of severe RSV disease. Here’s what you need to know about how often to get the RSV vaccine.
Why RSV Vaccination Matters
• RSV is a leading cause of hospitalization in infants and a significant contributor to severe respiratory illness in older adults.
• Unlike the flu, which circulates mainly in winter, RSV season can begin as early as late fall and extend into spring.
• Vaccination helps protect you and those around you from serious complications, including pneumonia and bronchitis.
Who Should Consider RSV Vaccination
Current guidance (based on U.S. Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices) recommends RSV vaccination for:
“How Often to Get RSV Vaccine” at a Glance
• Adults 60+ (and 18–59 with risk factors): One dose before each RSV season (fall–winter).
• Pregnant people: One dose per pregnancy, given between 32–36 weeks.
• Infants at high risk: Monthly palivizumab injections through RSV season or a single nirsevimab dose before season.
Adults 60 Years and Older (and Adults 18–59 with Risk Factors)
What to get
• RSVPreF3 (brand names: Arexvy or Abrysvo)
When to get it
• One dose each RSV season, ideally before community RSV activity starts (typically September–November).
• If you miss the early window, get vaccinated as soon as possible.
Why annual dosing?
• Protection may wane over time, and annual vaccination boosts immunity.
• RSV strains can vary season to season.
Pregnant People
What to get
• Abrysvo RSV vaccine (Pfizer)
When to get it
• A single dose between 32 and 36 weeks of gestation.
Why once per pregnancy?
• Maternal antibodies pass to the baby, offering protection during the first months of life—when infants face the highest risk.
• No current recommendation for repeat dosing within the same pregnancy.
Infants and Monoclonal Antibodies
Infants—especially those born before 29 weeks’ gestation or with serious heart or lung disease—may be eligible for passive immunization rather than a traditional vaccine.
Nirsevimab (Beyfortus)
• A one-time dose given before the start of RSV season (ideally by the time the infant is 8 months old if born during season).
• Provides season‐long protection.
Palivizumab (Synagis)
• Given monthly (up to five doses) during RSV season for the highest‐risk infants (those born before 29 weeks, or with certain heart/lung conditions).
• Administered intramuscularly.
Key Points on Scheduling
• Check local RSV activity: Your doctor or local health department can advise when season is expected to begin in your area.
• Coordinate with other vaccines: You can get RSV vaccine at the same visit as flu and COVID-19 vaccines.
• If you get RSV vaccine early in season, you don’t need a booster later that same season.
Common Questions
Q: Can I skip a season if I feel healthy?
A: Not recommended. You may still be exposed to new RSV strains, and immunity can decline. Annual vaccination is the best way to maintain protection.
Q: What if I already had RSV this season?
A: Natural infection does not guarantee lasting immunity. Speak with your doctor about whether vaccination is still beneficial.
Q: Is RSV vaccine safe during pregnancy?
A: Yes. Clinical trials and follow-up studies have shown the RSV vaccine to be safe and well tolerated in pregnant people, with the added benefit of protecting newborns.
Side Effects and Safety
• Most people experience mild side effects—soreness at the injection site, fatigue or headache.
• Serious reactions are rare.
• If you have a history of severe allergic reactions to any vaccine ingredient, talk with your healthcare provider.
Planning Your RSV Vaccine Appointment
Stay Vigilant for RSV Symptoms
Even after vaccination, it’s important to watch for RSV symptoms—especially in high-risk individuals. Common signs include:
If you or a loved one develops concerning symptoms, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide whether to seek medical attention.
When to Seek Medical Care
Always speak to a doctor if you experience:
• Difficulty breathing or rapid breathing
• Chest pain or persistent high fever
• Signs of dehydration (dry mouth, no tears, fewer wet diapers in infants)
• Any sudden or severe change in condition
Final Thoughts
Keeping up with annual RSV vaccination can significantly reduce your risk of serious illness—especially if you’re older, pregnant or have underlying health conditions. Infants at high risk benefit from targeted monoclonal antibodies each season. As with any medical decision, talk with your healthcare provider about what’s right for you and your family.
Speak to a doctor about anything that could be life-threatening or serious. Your health—and the health of those you love—depends on staying informed, protected and proactive.
(References)
* GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis. 2024 Sep;24(9):974-1002. doi: 10.1016/S1473-3099(24)00176-2. Epub 2024 Apr 15. PMID: 38636536; PMCID: PMC11339187.
* Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, Baker J, Pérez Marc G, Radley D, Shittu E, Glanternik J, Snaggs H, Baber J, Zachariah P, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Duron Padilla M, Richmond PC, Koury K, Schneider K, Kalinina EV, Cooper D, Jansen KU, Anderson AS, Swanson KA, Gruber WC, Gurtman A, MATISSE Study Group. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5. PMID: 37018474.
* Papi A, Ison MG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Campora L, Dezutter N, de Schrevel N, Fissette L, David MP, Van der Wielen M, Kostanyan L, Hulstrøm V, AReSVi-006 Study Group. Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults. N Engl J Med. 2023 Feb 16;388(7):595-608. doi: 10.1056/NEJMoa2209604. PMID: 36791160.
* Phijffer EW, de Bruin O, Ahmadizar F, Bont LJ, Van der Maas NA, Sturkenboom MC, Wildenbeest JG, Bloemenkamp KW. Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes. Cochrane Database Syst Rev. 2024 May 2;5(5):CD015134. doi: 10.1002/14651858.CD015134.pub2. Epub 2024 May 2. PMID: 38695784; PMCID: PMC11064886.
* Walsh EE, Pérez Marc G, Zareba AM, Falsey AR, Jiang Q, Patton M, Polack FP, Llapur C, Doreski PA, Ilangovan K, Rämet M, Fukushima Y, Hussen N, Bont LJ, Cardona J, DeHaan E, Castillo Villa G, Ingilizova M, Eiras D, Mikati T, Shah RN, Schneider K, Cooper D, Koury K, Lino MM, Anderson AS, Jansen KU, Swanson KA, Gurtman A, Gruber WC, Schmoele-Thoma B, RENOIR Clinical Trial Group. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults. N Engl J Med. 2023 Apr 20;388(16):1465-1477. doi: 10.1056/NEJMoa2213836. Epub 2023 Apr 5. PMID: 37018468.
* Scott J, Abers MS, Marwah HK, McCann NC, Meyerowitz EA, Richterman A, Fleming DF, Holmes EJ, Moat LE, Redepenning SG, Smith EA, Stoddart CJ, Sundaram ME, Ulrich AK, Alba C, Anderson CJ, Arpey MK, Borre E, Ladines-Lim J, Mehr AJ, Rich K, Watts C, Basta NE, Jarolimova J, Walensky RP, Dugdale CM. Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026. N Engl J Med. 2025 Dec 4;393(22):2221-2242. doi: 10.1056/NEJMsa2514268. Epub 2025 Oct 29. PMID: 41160817.
* Surie D, Self WH, Yuengling KA, Lauring AS, Zhu Y, Safdar B, Ginde AA, Simon SJ, Peltan ID, Brown SM, Gaglani M, Ghamande S, Columbus C, Mohr NM, Gibbs KW, Hager DN, Prekker M, Gong MN, Mohamed A, Johnson NJ, Steingrub JS, Khan A, Duggal A, Gordon AJ, Qadir N, Chang SY, Mallow C, Felzer JR, Kwon JH, Exline MC, Vaughn IA, Ramesh M, Papalambros L, Mosier JM, Harris ES, Baughman A, Cornelison SA, Blair PW, Johnson CA, Lewis NM, Ellington S, Grijalva CG, Talbot HK, Casey JD, Halasa N, Chappell JD, Rutkowski RE, Ma KC, Dawood FS, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network. RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. JAMA. 2025 Oct 28;334(16):1442-1451. doi: 10.1001/jama.2025.15896. PMID: 40884491; PMCID: PMC12398767.
* Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Verheust C, Dezutter N, Gruselle O, Fissette L, David MP, Kostanyan L, Hulstrøm V, Olivier A, Van der Wielen M, Descamps D, AReSVi-006 Study Group. Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons. Clin Infect Dis. 2024 Jun 14;78(6):1732-1744. doi: 10.1093/cid/ciae010. PMID: 38253338; PMCID: PMC11175669.
* Wilson E, Goswami J, Baqui AH, Doreski PA, Perez-Marc G, Zaman K, Monroy J, Duncan CJA, Ujiie M, Rämet M, Pérez-Breva L, Falsey AR, Walsh EE, Dhar R, Wilson L, Du J, Ghaswalla P, Kapoor A, Lan L, Mehta S, Mithani R, Panozzo CA, Simorellis AK, Kuter BJ, Schödel F, Huang W, Reuter C, Slobod K, Stoszek SK, Shaw CA, Miller JM, Das R, Chen GL, ConquerRSV Study Group. Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults. N Engl J Med. 2023 Dec 14;389(24):2233-2244. doi: 10.1056/NEJMoa2307079. PMID: 38091530.
* Madhi SA, Polack FP, Piedra PA, Munoz FM, Trenholme AA, Simões EAF, Swamy GK, Agrawal S, Ahmed K, August A, Baqui AH, Calvert A, Chen J, Cho I, Cotton MF, Cutland CL, Englund JA, Fix A, Gonik B, Hammitt L, Heath PT, de Jesus JN, Jones CE, Khalil A, Kimberlin DW, Libster R, Llapur CJ, Lucero M, Pérez Marc G, Marshall HS, Masenya MS, Martinón-Torres F, Meece JK, Nolan TM, Osman A, Perrett KP, Plested JS, Richmond PC, Snape MD, Shakib JH, Shinde V, Stoney T, Thomas DN, Tita AT, Varner MW, Vatish M, Vrbicky K, Wen J, Zaman K, Zar HJ, Glenn GM, Fries LF, Prepare Study Group. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. N Engl J Med. 2020 Jul 30;383(5):426-439. doi: 10.1056/NEJMoa1908380. PMID: 32726529; PMCID: PMC7299433.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.